Provided by Tiger Trade Technology Pte. Ltd.

Provident

23.06
-0.0900-0.39%
Post-market: 23.060.0025+0.01%19:30 EDT
Volume:1.94M
Turnover:44.74M
Market Cap:3.01B
PE:9.62
High:23.11
Open:23.09
Low:22.79
Close:23.15
52wk High:25.49
52wk Low:17.69
Shares:130.62M
Float Shares:126.13M
Volume Ratio:2.05
T/O Rate:1.54%
Dividend:0.96
Dividend Rate:4.17%
EPS(TTM):2.40
EPS(LYR):2.23
ROE:11.14%
ROA:1.25%
PB:1.04
PE(LYR):10.33

Loading ...

Provident Financial Services, Inc. Announces Pricing of Subordinated Notes Offering

THOMSON REUTERS
·
Aug 21

Leads Biolabs’ Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Abstract Published by WCLC: Extended Follow‑Up Shows Continued Efficacy Improvement

GlobeNewswire
·
Aug 20

Provident Financial EVP, CRBO Vito Giannola Sells 20,000 Shares for $487,200

Reuters
·
Aug 19

Biodexa announces major milestone for its Serenta registrational Phase 3 trial in FAP

GlobeNewswire
·
Aug 19

PC Gold Reports Strong Metallurgical Test Results at Spring Hill Gold Project

MT Newswires Live
·
Aug 19

Wallbridge Restarts Fenelon Operations, Refocuses 2026 Drilling on PFS Work

TIPRANKS
·
Aug 18

Press Release: Immatics Announces Second Quarter 2026 Financial Results and Business Update

Dow Jones
·
Aug 18

Unico Silver Delays Argentina PFS to Boost Resource Confidence and Processing Options

TIPRANKS
·
Aug 18

Australian Mines Confirms Valid Water Access Licence for NSW Scandium Project, Shares Down 8%

MT Newswires Live
·
Aug 17

AngloGold Ashanti in $42M deal to double Thesis stake

Mining
·
Aug 17

Press Release: LeonaBio Reports Second Quarter 2026 Financial Results and Provides Business Update

Dow Jones
·
Aug 15

GT Biopharma Reports Second Quarter 2026 Financial Results

GlobeNewswire
·
Aug 14

Press Release: Caribou Biosciences Reports Second Quarter 2026 Financial Results and Provides Business Update

Dow Jones
·
Aug 14

PDS Biotech Reports Second Quarter 2026 Financial Results

GlobeNewswire
·
Aug 13

Press Release: ADC Therapeutics Reports Second Quarter 2026 Financial Results and Provides Operational Updates

Dow Jones
·
Aug 13

Otsuka Subsidiary's Lung Cancer Drug Trial Meets Primary PFS Endpoint

MT Newswires Live
·
Aug 13

Press Release: Adagene Reports Six Months 2026 Financial Results and Provides Corporate Updates

Dow Jones
·
Aug 12

3 Reliable Dividend Stocks Yielding Up To 4.8%

Simply Wall St.
·
Aug 11

Viridis Demo Plant Outperforms PFS as Colossus Rare Earths Move Toward DFS

TIPRANKS
·
Aug 07

Provident Financial Services Director Michael Edward Regan Files Initial Beneficial Ownership Statement

Reuters
·
Aug 06